Axxess Pharma Inc. is a specialty pharmaceutical company headquartered in Markham, Ontario. The company was founded by Everett Sequeira. Everett has successfully developed commercial, scientific and regulatory components for an efficient pharmaceutical and diagnostic organization. Since 1997, Axxess Pharma has marketed and distributed various pharmaceutical products and diagnostic medical devices.

Products are obtained through acquisition, licensing and distributorship arrangements and include the following:

  • Axxess Pharma acquired and owns 22 established pharmaceutical prescription products that have proven sales in Canada and internationally;
  • Axxess has licensed Monurol a single dose antibiotic, specific treatment for Urinary track infections with Zambon SPA Switzerland. And exclusive license for marketing, and distribution of Trans dermal patches, and cosmetic masks and patches with Caleb Pharma.
  • Axxess Pharma out sources the manufacturing of pharmaceutical, diagnostic, and other whole blood tests.

Axxess distribution network includes:

  • Physicians;
  • Hospitals;
  • Government and defense institutions; and
  • Pharmacies

Operations

Axxess Pharma Inc. Identifies, develops and delivers pharmaceutical products that make a difference to the medical profession. We believe that a carefully selected portfolio of products with a strategically aligned and specialized sales force shall deliver strong results.

We execute superior marketing and sales initiatives to firmly establish our products in the marketplace.

The current in-line products are effective and unique, have gained physician recognition, and have met regulatory requirements. Axxess Pharma has established the following:

  • Regulatory and Quality Assurance personnel and facilities;
  • Effective national distribution for product availability to hospitals, pharmacies and physicians;
  • Registration on various provincial formularies;
  • Importation and exportation of pharmaceutical and diagnostic products globally;
  • Establishment of scientific data base to support product claims, product recalls and in-house physician consultation; and
  • Development of appropriate links with scientific community.